Cargando…
Avatrombopag Optimizes Response to Niraparib by Managing Thrombocytopenia Associated with Poly-ADP Ribose Polymerase (PARP) Inhibition in Ovarian Cancer and Breast Cancer: A Case Series
Case series Patients:— Final Diagnosis: Breast cancer • ovarian cancer Symptoms: Thrombocytopenia Medication: — Clinical Procedure: — Specialty: Oncology OBJECTIVE: Unusual or unexpected effect of treatment BACKGROUND: Thrombocytopenia is a potentially treatment-limiting adverse event of particular...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
International Scientific Literature, Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682497/ https://www.ncbi.nlm.nih.gov/pubmed/33191394 http://dx.doi.org/10.12659/AJCR.927008 |